Hochedlinger K - Search Results

1

Chromatin-state barriers enforce an irreversible mammalian cell fate decision.

Blanco MA, Sykes DB, Gu L, Wu M, Petroni R, Karnik R, Wawer M, Rico J, Li H, Jacobus WD, Jambhekar A, Cheloufi S, Meissner A, Hochedlinger K, Scadden DT, Shi Y. Blanco MA, et al. Among authors: hochedlinger k. Cell Rep. 2021 Nov 9;37(6):109967. doi: 10.1016/j.celrep.2021.109967. Cell Rep. 2021. PMID: 34758323 Free article.

2

Correction of a genetic defect by nuclear transplantation and combined cell and gene therapy.

Rideout WM 3rd, Hochedlinger K, Kyba M, Daley GQ, Jaenisch R. Rideout WM 3rd, et al. Among authors: hochedlinger k. Cell. 2002 Apr 5;109(1):17-27. doi: 10.1016/s0092-8674(02)00681-5. Cell. 2002. PMID: 11955443 Free article.

3

Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues.

Hochedlinger K, Yamada Y, Beard C, Jaenisch R. Hochedlinger K, et al. Cell. 2005 May 6;121(3):465-77. doi: 10.1016/j.cell.2005.02.018. Cell. 2005. PMID: 15882627 Free article.

4

In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state.

Wernig M, Meissner A, Foreman R, Brambrink T, Ku M, Hochedlinger K, Bernstein BE, Jaenisch R. Wernig M, et al. Among authors: hochedlinger k. Nature. 2007 Jul 19;448(7151):318-24. doi: 10.1038/nature05944. Epub 2007 Jun 6. Nature. 2007. PMID: 17554336

5

Oct4 expression is not required for mouse somatic stem cell self-renewal.

Lengner CJ, Camargo FD, Hochedlinger K, Welstead GG, Zaidi S, Gokhale S, Scholer HR, Tomilin A, Jaenisch R. Lengner CJ, et al. Among authors: hochedlinger k. Cell Stem Cell. 2007 Oct 11;1(4):403-15. doi: 10.1016/j.stem.2007.07.020. Cell Stem Cell. 2007. PMID: 18159219 Free PMC article.

6

Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse.

Stadtfeld M, Maherali N, Breault DT, Hochedlinger K. Stadtfeld M, et al. Among authors: hochedlinger k. Cell Stem Cell. 2008 Mar 6;2(3):230-40. doi: 10.1016/j.stem.2008.02.001. Epub 2008 Feb 14. Cell Stem Cell. 2008. PMID: 18371448 Free PMC article.

7

Disease-specific induced pluripotent stem cells.

Park IH, Arora N, Huo H, Maherali N, Ahfeldt T, Shimamura A, Lensch MW, Cowan C, Hochedlinger K, Daley GQ. Park IH, et al. Among authors: hochedlinger k. Cell. 2008 Sep 5;134(5):877-86. doi: 10.1016/j.cell.2008.07.041. Epub 2008 Aug 7. Cell. 2008. PMID: 18691744 Free PMC article.

8

Guidelines and techniques for the generation of induced pluripotent stem cells.

Maherali N, Hochedlinger K. Maherali N, et al. Among authors: hochedlinger k. Cell Stem Cell. 2008 Dec 4;3(6):595-605. doi: 10.1016/j.stem.2008.11.008. Cell Stem Cell. 2008. PMID: 19041776 Free article. Review.

9

Cross-regulation of the Nanog and Cdx2 promoters.

Chen L, Yabuuchi A, Eminli S, Takeuchi A, Lu CW, Hochedlinger K, Daley GQ. Chen L, et al. Among authors: hochedlinger k. Cell Res. 2009 Sep;19(9):1052-61. doi: 10.1038/cr.2009.79. Epub 2009 Jun 30. Cell Res. 2009. PMID: 19564890

10

Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells.

Eminli S, Foudi A, Stadtfeld M, Maherali N, Ahfeldt T, Mostoslavsky G, Hock H, Hochedlinger K. Eminli S, et al. Among authors: hochedlinger k. Nat Genet. 2009 Sep;41(9):968-76. doi: 10.1038/ng.428. Epub 2009 Aug 9. Nat Genet. 2009. PMID: 19668214 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

152 results

Search Page